Unity Biotechnology

Mizuho reaffirmed their purchase rating on portions of Unity Biotechnology (NASDAQ: UBX) in an exploration note discharged on Monday, November eighteenth, AnalystRatings.com reports. They at present have a $33.00 value focus on the stock.

A few different values look into examiners have additionally remarked on the organization. Cantor Fitzgerald emphasized an overweight rating on portions of Unity Biotechnology in an exploration note....